Anti-LRC8D/ LRRC8D/ LRRC5 monoclonal antibody

Anti-LRC8D/ LRRC8D/ LRRC5 antibody for FACS & in-vivo assay

Target products collectionGo to LRRC8D/LRRC8D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0770-Ab-1/ GM-Tg-hg-MP0770-Ab-2Anti-Human LRRC8D monoclonal antibodyHuman
GM-Tg-rg-MP0770-Ab-1/ GM-Tg-rg-MP0770-Ab-2Anti-Rat LRRC8D monoclonal antibodyRat
GM-Tg-mg-MP0770-Ab-1/ GM-Tg-mg-MP0770-Ab-2Anti-Mouse LRRC8D monoclonal antibodyMouse
GM-Tg-cynog-MP0770-Ab-1/ GM-Tg-cynog-MP0770-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRC8D monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0770-Ab-1/ GM-Tg-felg-MP0770-Ab-2Anti-Feline LRRC8D monoclonal antibodyFeline
GM-Tg-cang-MP0770-Ab-1/ GM-Tg-cang-MP0770-Ab-2Anti-Canine LRRC8D monoclonal antibodyCanine
GM-Tg-bovg-MP0770-Ab-1/ GM-Tg-bovg-MP0770-Ab-2Anti-Bovine LRRC8D monoclonal antibodyBovine
GM-Tg-equg-MP0770-Ab-1/ GM-Tg-equg-MP0770-Ab-2Anti-Equine LRRC8D monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0770-Ab-1/ GM-Tg-hg-MP0770-Ab-2; GM-Tg-rg-MP0770-Ab-1/ GM-Tg-rg-MP0770-Ab-2;
GM-Tg-mg-MP0770-Ab-1/ GM-Tg-mg-MP0770-Ab-2; GM-Tg-cynog-MP0770-Ab-1/ GM-Tg-cynog-MP0770-Ab-2;
GM-Tg-felg-MP0770-Ab-1/ GM-Tg-felg-MP0770-Ab-2; GM-Tg-cang-MP0770-Ab-1/ GM-Tg-cang-MP0770-Ab-2;
GM-Tg-bovg-MP0770-Ab-1/ GM-Tg-bovg-MP0770-Ab-2; GM-Tg-equg-MP0770-Ab-1/ GM-Tg-equg-MP0770-Ab-2
Products NameAnti-LRRC8D monoclonal antibody
Formatmab
Target NameLRRC8D
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRRC8D benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LRC8D/ LRRC8D/ LRRC5 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004729mouse Lrrc8d Lentivirus plasmid
    ORF Viral VectorvGMLPm004729mouse Lrrc8d Lentivirus particle


    Target information

    Target IDGM-MP0770
    Target NameLRRC8D
    Gene ID55144,231549,305131,100423127,119872273,101083608,539204,100061270
    Gene Symbol and Synonyms2810473G09Rik,4930525N13Rik,A930019F03,HsLRRC8D,LOC119872273,LRRC5,LRRC8D
    Uniprot AccessionQ7L1W4,Q5U308
    Uniprot Entry NameLRC8D_HUMAN,LRC8D_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000171492
    Target ClassificationN/A

    The target: LRRC8D, gene name: LRRC8D, also named as LRRC5. Enables volume-sensitive anion channel activity. Involved in cellular response to osmotic stress; organic acid transport; and protein hexamerization. Located in cytoplasm and plasma membrane. Is integral component of plasma membrane. Part of ion channel complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.